Transcutaneous Electroacupuncture for Gastrointestinal Motility Disorders

计划入组 27 人 · 首次发布于 2020 年 4 月 16 日

Novel Antineuronal Antibodies in Gastrointestinal Motility Disorders

计划入组 300 人 · 首次发布于 2021 年 5 月 4 日

Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders

首次发布于 2021 年 5 月 4 日

mu opioid antagonists (oral/parenteral formulation, gastrointestinal motility disorders)

Pipenzolate

C₂₂H₂₈NO₃

Cinitapride

C₂₁H₃₀N₄O₄ · Rx

Institute For Neurodegenerative Disorders

United States

Ascendis Pharma Growth Disorders A/S

Denmark

Alzheimer's Disease And Related Disorders Association, Inc.

United States

FDA Clears RMIT-Developed Ingestible Gas Capsule for Diagnosing Gut Motility Disorders

AnX Robotica Receives FDA 510(k) Clearance for MotiliCap and MotiliScan GI Motility Monitoring System

Processa Pharmaceuticals Secures $452.5M Licensing Deal for Gastroparesis Drug PCS12852